Search results
Heather Bresch is a pharmaceutical executive who is currently the Chief Executive Officer of Mylan. Somewhat controversially, while increasing the emergency-use EpiPen, used to treat anaphylaxis from $56 to $317, Bresch's salary increased from $2M to $19M. Heather Bresch's House (Google Maps).
- Jack Ham's House
Jack Ham's House (Google Maps). The former professional...
- Kc-135 in Flight
Explore KC-135 in flight in Sewickley, PA as it appears on...
- Tom Barrasso's House (Former)
Sewickley, Pennsylvania (PA), US. The former National Hockey...
- Sidney Crosby's House (Former)
Sidney Crosby's House (former) (Google Maps). Former home of...
- Jack Ham's House
Sep 12, 2016 · Heather Bresch and husband hit with liens on Sewickley Heights home. Mylan CEO Heather Bresch earned $19 million last year, but she and her husband dropped the ball on paying a $23 tax...
- PITTSBURGH
Nov 10, 2023 · Inside her $10 million home in Pittsburgh Heather Bresch lives with her husband and four children in Sewickley Heights, Pennsylvania. The Bresches own a 27-acre property that includes a pool, a barn, and a pond with multiple waterfalls.
Oct 12, 2021 · The activists outside of Bresch's home requested that she help lobby her father to support the full $3.5 trillion reconciliation bill, which would include funding for free community college,...
Aug 24, 2016 · Heather Bresch is a pharmaceutical executive who is currently the Chief Executive Officer of Mylan. Somewhat controversially, while increasing the emergency-use EpiPen, used to treat anaphylaxis from $56 to $317, Bresch's salary increased from $2M to $19M.
Apr 26, 2013 · No. 1, 202-204 Scaife Road in Sewickley Heights, was bought by Jeffrey Bresch and Mylan Inc. CEO Heather Bresch from IPEG Inc. Chairman G. Watts Humphrey and Sally K. Humphrey for $2.85...
Heather Bresch (née Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan , becoming the first woman to run a Fortune 500 pharmaceutical company. [3]